M7M-19458-23039
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 493 / MI
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Headache, Pain — Feeling: GoodFree text: Slight aches and headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 28, dose 2MedDRA: Chills, Cough, Nausea, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Sore throat, runny nose, nausea/chills, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-03-02
-
2021-04-20
Survey response — 3 months, dose 2MedDRA: Gestational diabetes — Feeling: GoodFree text: Gestational diabetesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-20
-
2022-01-19
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Had COVID 19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech |
Free text
Release 1 — day 14, dose 1
Symptoms: Slight aches and headache
Release 4 — day 28, dose 2
Symptoms: Sore throat, runny nose, nausea/chills, cough
Release 7 — 3 months, dose 2
Symptoms: Gestational diabetes
Release 10 — 12 months, dose 2
Symptoms: Had COVID 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Gestational diabetes | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release